Understanding Diffuse Alveolar Hemorrhage (DAH)
At a Glance
Diffuse Alveolar Hemorrhage (DAH) is a medical emergency where blood leaks into the lung's air sacs, often causing severe shortness of breath and anemia. It is usually triggered by an underlying immune condition and treated effectively with high-dose corticosteroids to stop inflammation.
It is completely natural to feel overwhelmed or even panicked right now. Hearing that there is bleeding in your lungs is frightening, but understanding what is happening in your body is the first step toward regaining a sense of control. Diffuse Alveolar Hemorrhage (DAH) is a serious medical emergency, but with rapid diagnosis and the aggressive treatments available today, medical teams can often halt the process and support your recovery [1][2].
What is Diffuse Alveolar Hemorrhage?
At its simplest level, DAH means that blood is leaking into the alveoli, which are the tiny air sacs in your lungs where oxygen enters your bloodstream [1]. Under normal conditions, a very thin barrier—the alveolar-capillary membrane—keeps your blood and your air separate. In DAH, this membrane is damaged or disrupted, allowing blood to spill into the spaces meant for air [3][4].
While you might experience a cough that brings up blood (hemoptysis), this does not happen for everyone (see Recognizing the Symptoms) [5]. Instead, the primary signs are often a sudden drop in your blood count (anemia) and increasing difficulty breathing as the blood prevents the air sacs from doing their job [1][5].
Three Facts to Hold Onto
When you are in the middle of a medical crisis, it helps to focus on a few stabilizing truths:
- DAH is a “syndrome,” not a final diagnosis. DAH is usually a signal that something else is happening in the body, such as an overactive immune system or a reaction to a medication [6][7]. Because doctors treat the underlying cause, identifying that trigger is the top priority.
- Modern treatments are highly effective. Doctors have powerful tools to stop the inflammation causing the leak. This often involves “pulse” therapy—high doses of corticosteroids (anti-inflammatory drugs) to quickly calm the immune response [8][9].
- In-hospital outcomes have improved. While DAH is a critical condition, current management strategies—including rapid multidisciplinary care between lung and kidney specialists—have made survival and functional recovery much more common than in the past [10][11].
The Lung-Kidney Connection (Pulmonary-Renal Syndrome)
In many cases, the same process attacking the blood vessels in your lungs may also be affecting your kidneys. This is known as Pulmonary-Renal Syndrome (PRS) [5].
The kidneys and the lungs share similar types of tiny blood vessels and “basement membranes.” If your immune system begins attacking these structures—as seen in conditions like ANCA-associated vasculitis or anti-GBM disease—it can cause inflammation in both organs simultaneously [5][12]. In the kidneys, this often shows up as glomerulonephritis, an inflammation that can make your urine look dark (from spilled red blood cells) or foamy (from leaked protein) [5][13]. If your doctors suspect PRS, they will likely have a team of pulmonologists (lung doctors) and nephrologists (kidney doctors) working together to protect both organ systems [5][14].
Why This Happens
DAH is frequently “immune-mediated,” meaning the body’s defense system is mistakenly attacking its own tissues [15]. Common triggers include:
- Systemic Vasculitis: Inflammation of the blood vessels throughout the body [6].
- Connective Tissue Diseases: Conditions like systemic lupus erythematosus (SLE) [8].
- External Triggers: Certain medications (like blood thinners or hydralazine) or inhaled substances can occasionally cause the lungs to bleed [7][16].
By identifying the specific “why” behind the bleeding (see Causes of DAH and Diagnosis & BAL Results), your care team can tailor your treatment to stop the damage (see Standard of Care Treatment). Once stable, the focus shifts to your Prognosis and long-term Survivorship [17][1].
In this guide
6 chapters
Recognizing the Symptoms of DAH
Learn the classic symptoms of Diffuse Alveolar Hemorrhage (DAH), including anemia and shortness of breath, and why coughing up blood isn't always present.
Causes of DAH: Immune vs. Non-Immune
Learn the causes of Diffuse Alveolar Hemorrhage (DAH). Understand the differences between immune-mediated diseases and non-immune triggers for your care.
Diagnosis and Understanding Your BAL Results
Learn how Diffuse Alveolar Hemorrhage (DAH) is diagnosed. Understand your BAL results, hemosiderin-laden macrophages, HRCT scans, and kidney biopsies.
Standard of Care Treatment for DAH
Learn about the standard treatments for Diffuse Alveolar Hemorrhage (DAH). Understand the phases of care, from stabilization to induction and maintenance.
Prognosis and Risk Stratification
Understand your long-term prognosis after Diffuse Alveolar Hemorrhage (DAH). Learn about the Five-Factor Score, relapse risks, and remission monitoring.
Life After DAH: Survivorship and Monitoring
Learn what to expect during Diffuse Alveolar Hemorrhage (DAH) recovery. Understand maintenance therapy, monitoring schedules, and signs of a DAH relapse.
Common questions in this guide
What causes diffuse alveolar hemorrhage?
Why are my kidneys being checked if I have bleeding in my lungs?
Does everyone with DAH cough up blood?
How is DAH treated?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my tests, what is the most likely cause of the bleeding in my lungs?
- 2.How are my kidneys functioning, and do we need to involve a nephrologist in my care?
- 3.What specific medications are being used to stop the inflammation, and how soon should we see a response?
- 4.Is there a specific underlying condition, like a vasculitis or lupus, that triggered this?
- 5.Are there any signs of infection that might be complicating the diagnosis?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (17)
- 1
Diffuse Alveolar Hemorrhage.
Murray J, O'Brien S, Mitchell PD
Seminars in respiratory and critical care medicine 2025; doi:10.1055/a-2725-7274.
PMID: 41130281 - 2
[Diffuse alveolar hemorrhage - acute, life-threatening situation in rheumatology].
Bradna P, Maňák J, Soukup T, et al.
Vnitrni lekarstvi 2018; (64(2)):169-172.
PMID: 29595282 - 3
Diffuse alveolar hemorrhage and acute eosinophilic pneumonia: A rare form of amiodarone pulmonary toxicity diagnosed by bronchoalveolar lavage.
Anai S, Nakayama Y, Gushiken H, et al.
Journal of cardiology cases 2023; (27(3)):93-96 doi:10.1016/j.jccase.2022.10.012.
PMID: 36910038 - 4
Recurrent idiopathic pulmonary hemosiderosis after long-term remission presented with Sjogren's syndrome: Idiopathic no more?
Yanagihara T, Yamamoto Y, Hamada N, et al.
Respiratory medicine case reports 2018; (25()):68-72 doi:10.1016/j.rmcr.2018.06.013.
PMID: 29984151 - 5
Pulmonary renal syndrome: a clinical review.
Boyle N, O'Callaghan M, Ataya A, et al.
Breathe (Sheffield, England) 2022; (18(4)):220208 doi:10.1183/20734735.0208-2022.
PMID: 36865943 - 6
Anti-Glomerular Basement Membrane Disease.
Gulati K, McAdoo SP
Rheumatic diseases clinics of North America 2018; (44(4)):651-673 doi:10.1016/j.rdc.2018.06.011.
PMID: 30274629 - 7
Anticoagulant Use as an Independent Risk Factor and Higher In-Hospital Mortality in Patients Showing Alveolar Hemorrhage in Diffuse Lung Disease.
Ugajin M, Kani H, Hattori H
Medicina (Kaunas, Lithuania) 2021; (57(10)) doi:10.3390/medicina57101094.
PMID: 34684131 - 8
Systemic lupus erythematosus and diffuse alveolar hemorrhage, etiology and novel treatment strategies.
Al-Adhoubi NK, Bystrom J
Lupus 2020; (29(4)):355-363 doi:10.1177/0961203320903798.
PMID: 32036761 - 9
Diffuse Alveolar Hemorrhage Developing Immediately after Immunosuppressive Treatments in a Patient with Granulomatosis with Polyangiitis Who Had Pulmonary Nodules.
Watanabe C, Fukui S, Iwamoto N, et al.
Internal medicine (Tokyo, Japan) 2018; (57(3)):417-421 doi:10.2169/internalmedicine.9188-17.
PMID: 29093401 - 10
Diffuse Alveolar Hemorrhage in Primary Versus Secondary Antiphospholipid Syndrome.
Sangli SS, Ryu JH, Baqir M
Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases 2021; (27(8)):e297-e301 doi:10.1097/RHU.0000000000001358.
PMID: 32195850 - 11
Methylprednisolone pulse therapy rescued life-threatening pulmonary hemorrhage due to idiopathic pulmonary hemosiderosis.
Li YT, Guo YX, Cai LM, et al.
The American journal of emergency medicine 2017; (35(11)):1786.e3-1786.e7 doi:10.1016/j.ajem.2017.07.094.
PMID: 28784257 - 12
Malignant Hypertension Causing a Pulmonary-Renal Syndrome.
Yong B, Power DA
Case reports in nephrology 2018; (2018()):3273695 doi:10.1155/2018/3273695.
PMID: 30652035 - 13
A Rare Sequela of Untreated Streptococcus Pharyngitis: A Case Report.
Lehoe MH, Cushing E
The Laryngoscope 2025; (135(6)):1940-1942 doi:10.1002/lary.32011.
PMID: 39835623 - 14
Nephrologist, Pulmonologist Connection: From Bench to Bedside, Mini Review.
Fadaii A, Kashefizadeh A, Jamalin SM, et al.
Iranian journal of kidney diseases 2020; (14(1)):8-11.
PMID: 32156835 - 15
Diffuse Alveolar Hemorrhage in Autoimmune Diseases.
Martínez-Martínez MU, Oostdam DAH, Abud-Mendoza C
Current rheumatology reports 2017; (19(5)):27 doi:10.1007/s11926-017-0651-y.
PMID: 28397125 - 16
Hemoptysis in a cannabis user.
Schattner A, Glick Y
The American journal of emergency medicine 2021; (49()):442.e1-442.e2 doi:10.1016/j.ajem.2021.05.003.
PMID: 34001429 - 17
Clinical characteristics of patients with diffuse alveolar hemorrhage diagnosed by cytological examination of 1000 bronchoalveolar lavage samples.
Prasad P, Gupta A, Nath A, et al.
Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG 2023; (40(1)):e2023004 doi:10.36141/svdld.v40i1.13413.
PMID: 36975056
This page provides an overview of Diffuse Alveolar Hemorrhage for educational purposes only. Always consult your pulmonologist, nephrologist, or critical care team for specific medical advice and treatment decisions.
Get notified when new evidence is published on Diffuse alveolar hemorrhage.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.